[Changes of circulating hematopoietic progenitor cells in patients undergoing coronary artery bypass graft surgery]

Lin Zhang1, Changqing Gao, Rong Wang

  • 1Department of Cardiovascular Surgery, General Hospital of PLA, Iinstitute of Cardiac Surgery of PLA, Beijing 100853, China.

Insights

Coronary artery bypass graft (CABG) surgery increases circulating hematopoietic progenitor cells (cHPCs) early post-operation. These cell levels return to normal over time, with greater changes observed in on-pump procedures.

Area of Science:

  • Cardiovascular Surgery
  • Hematology
  • Regenerative Medicine

Background:

  • Coronary artery bypass graft (CABG) surgery is a major cardiovascular procedure.
  • Hematopoietic progenitor cells (HPCs) play a crucial role in tissue repair and regeneration.
  • Understanding perioperative changes in circulating HPCs is important for assessing patient recovery.

Purpose of the Study:

  • To evaluate the dynamic changes in circulating hematopoietic progenitor cells (cHPCs) following CABG surgery.
  • To compare cHPC levels in patients undergoing on-pump versus off-pump CABG.
  • To assess the functional capacity of cHPCs post-CABG.

Main Methods:

  • Prospective study of 51 patients undergoing elective CABG.
  • Blood samples collected at baseline and 1, 3, and 5 days post-surgery.
  • Flow cytometry used to quantify CD34⁺, CD133⁺, and CD34⁺CD133⁺ HPCs; in vitro functional assays performed.

Main Results:

  • Significant postoperative increase in CD34⁺ CD45dim and CD133⁺ CD45dim cells observed.
  • Perioperative cHPC changes were more pronounced in on-pump CABG patients compared to off-pump.
  • Functional assays indicated progenitor cell activity post-surgery.

Conclusions:

  • Elective CABG surgery leads to an early, transient increase in circulating hematopoietic progenitor cells.
  • HPC levels normalize over time after CABG.
  • On-pump CABG elicits a more significant response in cHPC mobilization.
Abstract

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K